Organon & Co 2.875% | - | 3.01% | - | - | 5,140,000 |
| XS1793255941=TX | 2.28% | 102.95 | 0.00% | 3,650,000 | |
Vodafone Group PLC | - | 2.09% | - | - | 3,426,000 |
Valeo SE 5.375% | - | 1.94% | - | - | 3,100,000 |
Walgreens Boots Alliance Inc. 2.125% | - | 1.93% | - | - | 3,199,000 |
Nomad Foods Bondco Plc 2.5% | - | 1.92% | - | - | 3,280,000 |
Teva Pharmaceutical Finance Netherlands II B.V 3.75% | - | 1.79% | - | - | 2,938,000 |
OI European Group B.V. 6.25% | - | 1.72% | - | - | 2,740,000 |
ELO SA 5.875% | - | 1.69% | - | - | 2,700,000 |
Iliad SA 5.375% | - | 1.63% | - | - | 2,600,000 |
Amundi Index Solutions SICAV - Amundi EUR Short Term High Yield Corporate Bond ESG UCITS ETF is an exchange traded fund launched and managed by Amundi Asset Management SAS. It invests in the fixed income markets in Eurozone. The fund uses derivatives such as swaps to invest in Euro denominated fixed rate corporate bonds with maturity between 1 and 3 years. It invests in high yield securities that are rated as between BB+ and CCC- by S&P, BB+ and CCC by Fitch, and Ba1 and Caa3 by Moody’s. The fund seeks to replicate the performance of the BofA Merill Lynch BB-CCC 1-3Year Euro Developed Markets High Yield Constrained Index, by employing synthetic replication methodology. Amundi Index Solutions SICAV - Amundi EUR Short Term High Yield Corporate Bond ESG UCITS ETF was formed on June 1, 2017 and is domiciled in Luxembourg.